Advancing Every Day

You are focused on the big biological question and are poised to dramatically change millions of lives for the better. Successfully navigating through clinical trials requires a different set of core competencies and capabilities. For 25 years Aldevron has been a catalyst, advancing therapeutic and vaccine development through expert manufacturing, supporting our clients from discovery to commercialization.

You are focused on the big biological question and are poised to dramatically change millions of lives for the better. Successfully navigating through clinical trials requires a different set of core competencies and capabilities. For 25 years Aldevron has been a catalyst, advancing therapeutic and vaccine development through expert manufacturing, supporting our clients from discovery to commercialization.

1998
2000
2005
2009
2014
2016
2017
2018
2019
2020
2021
2022
2023
  • Aldevron Founded by Michael Chambers & John Ballantyne
  • GMP-Source Developed
  • 10,000 RG Plasmid  DNA Released
  • Aldevron  Madison WI Location Opened
  • First GMP Plasmid Released
  • Offer Inventoried Research-Grade CAS9 Enzyme
  • TA Assoc. Investment
  • Fist to Offer Inventory  cGMP SpyFi CAS9 Enzyme
  • Original GMP Facility Operational
  • Fist cGMP mRNA Mfg. & Release
  • 100,000 Plasmid DNA Lots Released
  • EQT Equity Stake
  • Linear Template Mfg. RNA COVID 19 Vaccine
  • Exp. Phase 1 of GMP Facility Operational
  • Kevin Ballinger joins as CEO
  • Phase 2 of GMP Facility Operational (RNA)
  • cGMP RNP Mfg. & Release
  • Aldevron Madison Campus Expansion & Renovation
  • Fargo Advanced Campus Expansion & Renovation
  • Aldevron Acquired by Danaher
  • Aldevron Acquires Nature Technologies
  • Phase 3 of GMP Facility Operational
  • >3,500 cGMP Plasmid DNA Lots Released
  • 165,000 Plasmid DNA Lots Released
  • Phase 4 of cGMP Facility Operational (RNA)
  • Aldevron Madison Campus Expansion & Renovation

25 years advancing breakthroughs